Essex, United Kingdom

Andrew Sharpe

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovations of Andrew Sharpe

Introduction

Andrew Sharpe is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as NADPH oxidase inhibitors. His work is crucial for addressing various disorders related to Nicotinamide adenine dinucleotide phosphate oxidase.

Latest Patents

Andrew Sharpe holds one patent titled "Compounds as NADPH oxidase inhibitors." This patent discloses new compounds and pharmaceutical compositions that are intended for the treatment and/or prophylaxis of conditions associated with NADPH oxidase. His innovative approach has the potential to impact the treatment landscape for related disorders.

Career Highlights

Throughout his career, Andrew has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Calliditas Therapeutics Suisse SA and UCB Biopharma Sprl. His experience in these organizations has contributed to his expertise and success as an inventor.

Collaborations

Due to space constraints, the details of Andrew Sharpe's collaborations will not be included in this article.

Conclusion

Andrew Sharpe's contributions to the field of pharmaceuticals through his innovative patent and career experiences highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…